Medical Advisory Board

Composed of leading senior research authorities on rosacea and basic research, the NRS medical advisory board evaluates research study proposals and approves the awarding of research grants. The board members also develop NRS medical scientific policies, and review and edit educational materials developed by the NRS.

Jonathan Wilkin, M.D.
Advisory Board Chairman
Former Director of Dermatologic and
Dental Drug Products
U.S. Food and Drug Administration
Leading authority on flushing and rosacea

Mark Dahl, M.D.
Chairman, Dermatology
Mayo Clinic Arizona
Former President, American Academy of Dermatology

Michael Detmar, M.D.
Associate Professor, Dermatology
Harvard Medical School
Professor of Pharmacogenomics
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology
Zurich, Switzerland
Leading authority on basic research, genomics and angiogenesis

Lynn Drake, M.D.
Harvard Medical School
Former President, American Academy of Dermatology

David Norris, M.D.
Chairman, Dermatology
University of Colorado
Former President, Society for Investigative Dermatology

Richard Odom, M.D.
Professor, Clinical Dermatology
University of California-San Francisco
Former President, American Academy of Dermatology

Frank Powell, M.D.
Consultant Dermatologist
Regional Centre of Dermatology
Mater Misericordiae Hospital
Dublin, Ireland
Leading European authority on rosacea

Bryan Sires, M.D.
Clinical Associate Professor of Ophthalmology
University of Washington
Leading authority on ocular rosacea

Diane Thiboutot, M.D.
Professor, Dermatology
Pennsylvania State University
Leading expert on clinical and basic research